ORIGINAL RESEARCH
Published on 26 Jun 2026
Antagonism of β-klotho signaling by peptide 19 impairs wheel running in male mice and potentiates the cisplatin-induced decrease in wheel running
doi 10.3389/fphar.2026.1800474
- 670 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Volume II: Metabolic reprogramming in cancer
Volume II: Metabolic reprogramming in cancer
1,321
Total downloads
9,086
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 22 May 2026
The role of L-Arginine metabolism in the hallmarks of cancer as an emerging pathway to drug design
doi 10.3389/fphar.2026.1851940
- 1,496 views
REVIEW
Published on 08 May 2026
Aerobic glycolysis-driven lactate accumulation and acidic tumor microenvironment in hepatocellular carcinoma: a vicious cycle promoting tumor progression
doi 10.3389/fphar.2026.1704729
- 1,616 views
- 1 citation
ORIGINAL RESEARCH
Published on 21 Apr 2026
Integrating multi-omics approaches reveals metabolic reprogramming and identifies PDHX as a candidate node in triptolide-treated non-small Cell lung cancer
doi 10.3389/fphar.2026.1785207
- 1,286 views
ORIGINAL RESEARCH
Published on 09 Mar 2026
Metabolic profiling of the TME uncovers the contrasting impacts of CKMT2 and PDE2A in CRC progression and therapeutic response
doi 10.3389/fphar.2026.1732137
- 1,517 views
- 1 citation
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Other participating journals
Frontiers in Oncology
- 3.4 impact factor
- 6.6 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: